Lifeway Foods Inc. reports developments tied to its kefir-centered fermented dairy business. The company manufactures and markets drinkable kefir, Organic Lifeway Kefir, farmer cheese, other cheeses, ProBugs products for children, frozen kefir and private-label dairy items through retail, broker and distributor channels.
Recurring news themes include financial results and sales outlooks, growth in kefir and farmer cheese demand, product collaborations with foodservice and wellness partners, and brand campaigns that position kefir as a protein-forward probiotic beverage. Company updates also cover distribution, product innovation and consumer-marketing activity across its fermented probiotic portfolio.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Lifeway Foods (NASDAQ: LWAY) announced on December 3, 2025 that it was named to Inc. magazine's 2025 Best in Business list in the Best Challenger Brands category.
The award recognizes companies that achieved notable business wins such as customer expansion, key product launches, market-share gains, and industry impact. CEO Julie Smolyansky described the recognition as validation of Lifeway's focus on innovation and expanding access to probiotic foods. The full list is available at inc.com/best-in-business.
Summary not available.
Summary not available.
Summary not available.
Lifeway Foods (Nasdaq: LWAY) expanded distribution so its Lifeway Farmer Cheese is now carried in 2,000 Walmart (WMT) stores nationwide as of Nov. 21, 2025.
The product is described as a small-batch, probiotic soft cheese with 15 grams of protein per serving, live and active cultures, no added sugar, and placement in the dairy aisle. The company cites rising consumer demand and double-digit year‑over‑year growth in refrigerated cultured dairy categories as drivers for the rollout.
Lifeway Foods (Nasdaq: LWAY) reported record Q3 2025 net sales of $57.1 million, a 24.0% year‑over‑year increase and ~29% on a comparable basis. The quarter delivered 300 basis points of gross margin expansion to 28.7% and net income of $3.5 million ($0.23 per share), up from $3.0 million the prior year. Lifeway completed the first stage of its Waukesha plant expansion in September, which management says increased capacity and operational efficiency. The company launched new products including Muscle Mates™ (20g protein, 5g creatine, 12 probiotic cultures) and expanded kefir partnerships. Lifeway reiterated a long‑term target of $45–$50 million in Adjusted EBITDA for FY 2027 and expects its strongest annual sales in FY 2025.